544312 — Hamps Bio Balance Sheet
0.000.00%
- IN₹228.69m
- IN₹257.01m
- IN₹85.17m
Annual balance sheet for Hamps Bio, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6.2 | 4.16 | 12.9 | 24.8 | 24.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.91 | 7.6 | 11.1 | 12 | 12.1 |
| Total Other Current Assets | |||||
| Total Current Assets | 13.3 | 12.3 | 24.4 | 42.4 | 46.2 |
| Net Property, Plant And Equipment | 21.5 | 26.1 | 25.6 | 57.6 | 80.7 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 36.4 | 39.6 | 51.5 | 128 | 152 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 18 | 20.7 | 14 | 18.7 | 31.7 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 26.4 | 26 | 17.7 | 39.9 | 70.4 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 10.1 | 13.6 | 33.7 | 88 | 81.8 |
| Total Liabilities & Shareholders' Equity | 36.4 | 39.6 | 51.5 | 128 | 152 |
| Total Common Shares Outstanding |